Tenzing Acquisition Corp. (44) | Uncategorized (9)
Recent Contracts
-
Description of Securities
(Filed With SEC on March 22, 2021)
-
Letter Agreement, dated as of October 28, 2015, by and between Marc Cantillon, MD and Reviva Pharmaceuticals, Inc
(Filed With SEC on December 18, 2020)
-
Letter Agreement, dated as of March 15, 2016, by and between Marc Cantillon, MD and Reviva Pharmaceuticals, Inc
(Filed With SEC on December 18, 2020)
-
Form of Assumed Option
(Filed With SEC on December 18, 2020)
-
Letter Agreement, dated as of December 14, 2020, by and between the Company, Maxim Group LLC and Maxim Partners LLC
(Filed With SEC on December 18, 2020)
-
Form of Backstop Agreement, by and among Tenzing Acquisition Corp., Reviva Pharmaceuticals, Inc., and the Investor named therein
(Filed With SEC on October 22, 2020)
-
Form of Lock-Up Agreement (General)
(Filed With SEC on July 24, 2020)
-
Lock-Up Agreement, dated as of July 20, 2020 by and among Dr. Bhat, Tenzing and the Purchaser Representative
(Filed With SEC on July 24, 2020)
-
Description of the Registrants securities registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended
(Filed With SEC on May 4, 2020)